Status:

COMPLETED

Placebo Controlled Trial of Dextromethorphan in Rett Syndrome

Lead Sponsor:

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Collaborating Sponsors:

The Johns Hopkins Institute for Clinical and Translational Research (ICTR)

Conditions:

Rett Syndrome

Eligibility:

All Genders

1-10 years

Phase:

PHASE2

Brief Summary

Dr. Sakkubai Naidu, Principal Investigator, is initiating a double blinded placebo controlled clinical drug trial using dextromethorphan (DM) in Rett Syndrome (RTT), at the Pediatric Clinical Research...

Detailed Description

The study will last for 3 months and will be limited to MECP2 mutation-positive children, one year - 9.99 years of age. This clinical trial, which is a placebo-controlled study, will randomize patient...

Eligibility Criteria

Inclusion

  • males and females who have classic or atypical RTT with a proven mutation in the MECP2 gene;
  • subjects must be between one year - 10 years of age.

Exclusion

  • those without an established mutation in the MECP2 gene;
  • those with mutations in the MECP2 gene but who have had brain resection or surgical intervention; for example, tumor, hydrocephalus, severe head trauma; or, an associated severe medical illnesses such as vasculopathies, malignancies, diabetes, thyroid dysfunction, etc;
  • those on medications that could interact with DM, e.g. MAO inhibitors, SSRI, sibutramine etc. to avoid a serotonin syndrome; quinidine and drugs metabolized by the CYP450 isoform CYP2D6 (e.g. amiodarone, haloperidol, propafenone, thioridazine);
  • those proven to be intermediate or slow metabolizers of DM;
  • those with reported adverse reactions to DM;
  • those whose pregnancy test is positive;
  • those showing poor compliance with any aspect of the study;
  • foster children.

Key Trial Info

Start Date :

March 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 26 2016

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT01520363

Start Date

March 1 2012

End Date

October 26 2016

Last Update

December 4 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Johns Hopkins Institute for Clinical and Translational Research

Baltimore, Maryland, United States, 21287